Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

In the Details: Diagnosing PsA Requires Drilling Down

Vanessa Caceres  |  February 26, 2025

If the patient’s symptoms are more inflammatory in nature, Dr. Mease will obtain a C-reactive protein (CRP) and/or sedimentation rate, along with possibly an X-ray, ultrasound or magnetic resonance imaging (MRI) assessment.

He also provides feedback to the referring dermatologist.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“Every time you see such a patient, it’s an educational opportunity to advance the understanding of the referring dermatologist about what are the key features of either generalized PsA or components of it, such as axial PsA,” Dr. Mease said.

Enthesitis & Inflammation

Dr. Hausmann asked how to determine when enthesitis is inflammatory, considering that conditions, such as Achilles tendinopathy, are common. One distinguishing factor is if significant trauma has occurred before the onset of an Achilles tendon problem, which could be an alternative explanation for the pain.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Oftentimes, patients with inflammatory enthesitis will not be able to describe a specific incident, like going hiking with too heavy a backpack or something like that as the etiology of their Achilles or plantar fascia or patellar enthesitis. So it may be spontaneous,” Dr. Mease said.

Another clue is duration. In comparison with symptoms that last for a couple of weeks and that reasonably respond to anti-inflammatory medications, inflammatory enthesitis will endure a lot longer. To distinguish inflammatory enthesitis from traumatic enthesopathy or fibromyalgic enthesalgia, ultrasound or event MRI may be helpful, according to Dr. Mease.

If it’s chest pain, MRI and ultrasound will not be helpful. Instead, Dr. Mease uses a diagnostic Medrol Dosepak.

“If the chest pain just melts away, I have a stronger idea that this could be an inflammatory enthesopathy involving the ligaments of the ribs as opposed to a cracked rib or a mechanical-type costochondral problem,” he said.

Choosing a Treatment

With so many treatments available for PsA, Dr. Mease favors treatment recommendations from the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis. The group has existed for more than 20 years, and members periodically update its treatment recommendations.1

Some treatment considerations include whether the patient has peripheral arthritis, enthesitis, dactylitis and concomitant ulcerative colitis, Crohn’s disease or uveitis.

“All of these things go into the mix in addition to safety factors as we’re thinking about which medicines to bring up for the patient,” Dr. Mease said.

Often, Dr. Mease will discuss different options with patients to get their input on medication decisions. They may also discuss things with the referring dermatologist and then have a quick virtual visit to settle on a medicine. This approach often includes working with a staff member who pursues prior authorization from insurance.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsPsoriatic Arthritis Tagged with:ACR on AirEnthesitispatient carepodcastPsA

Related Articles

    Case Report: A Psoriatic Arthritis Patient with Dactylitis & Enthesitis

    September 20, 2018

    A 36-year-old woman presented at the Johns Hopkins Arthritis Center for a second opinion regarding a diagnosis of psoriatic arthritis (PsA). One year prior to our evaluation, she had developed pain and stiffness in her hands, feet, knees, ankles, elbows and shoulders. She had mild plaque psoriasis of the scalp and base of the neck,…

    The Heterogeneity of Psoriatic Arthritis

    November 21, 2023

    SAN DIEGO—Differences between psoriatic arthritis and rheumatoid arthritis highlight the need for the development of imaging modalities, laboratory tests and other biomarkers that are explored and validated specifically for PsA to advance the goal of personalized or precision medicine. In this article, expert David S. Pisetsky, MD, PhD, explores the top research in psoriatic arthritis presented at ACR Convergence 2023.

    Psoriatic Arthritis: Advances in Therapeutics, Imaging & More Presented at ACR Convergence 2022

    December 1, 2022

    PHILADELPHIA—Selecting my top 10 picks for abstracts in psoriatic arthritis (PsA) at the ACR Convergence 2022 meeting was not easy because there was a great deal to review and learn from the 139 abstracts submitted to the meeting. I focused first and foremost on advances in therapeutics that encompassed both new and approved therapeutics, novel…

    Top Research in Psoriatic Arthritis Presented at ACR Convergence 2024

    November 26, 2024

    Editor’s note: What research on psoriatic arthritis (PsA) presented at ACR Convergence 2024 has the greatest potential for a positive impact on clinical care, treatment options or serve as the basis for future research? That’s the question The Rheumatologist asked David S. Pisetsky, MD, PhD—our founding editor—to consider. Dr. Pisetsky, a professor of medicine and immunology…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences